利妥昔单抗治疗僵人综合征
Treatment of stiff person syndrome with rituximab.
作者信息
Baker M R, Das M, Isaacs J, Fawcett P R W, Bates D
机构信息
Department of Neurology, Royal Victoria Infirmary Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK.
出版信息
J Neurol Neurosurg Psychiatry. 2005 Jul;76(7):999-1001. doi: 10.1136/jnnp.2004.051144.
Abstract
This case report is about the novel use of the anti-CD20 antibody, rituximab, in the treatment of a 41 year old woman with stiff person syndrome. She was admitted to hospital as an emergency with prolonged and painful extensor spasms affecting the neck and back, arms, and legs. The disease had progressed despite a favourable initial response to conventional treatment with intravenous immunoglobulin and cytotoxics. Treatment with rituximab induced a lasting clinical remission.
摘要
本病例报告介绍了抗CD20抗体利妥昔单抗在治疗一名41岁僵人综合征女性患者中的新应用。她因颈部、背部、手臂和腿部持续性疼痛性伸肌痉挛而紧急入院。尽管最初对静脉注射免疫球蛋白和细胞毒性药物的常规治疗反应良好，但病情仍在进展。利妥昔单抗治疗诱导了持久的临床缓解。
相似文献
1
Treatment of stiff person syndrome with rituximab.利妥昔单抗治疗僵人综合征
J Neurol Neurosurg Psychiatry. 2005 Jul;76(7):999-1001. doi: 10.1136/jnnp.2004.051144.
2
Successful treatment with rituximab in a patient with stiff-person syndrome complicated by dysthyroid ophthalmopathy.利妥昔单抗成功治疗1例合并甲状腺功能障碍性眼病的僵人综合征患者。
Intern Med. 2010;49(3):237-41. doi: 10.2169/internalmedicine.49.2821. Epub 2010 Feb 1.
3
Teaching NeuroImages: Severe spasms resembling status dystonicus as an unusual presentation of stiff-person syndrome.教学神经影像：类似肌张力障碍状态的严重痉挛作为僵人综合征的一种不寻常表现
Neurology. 2019 Feb 12;92(7):e748. doi: 10.1212/WNL.0000000000006925.
4
Stiff-person syndrome: persistent elevation of glutamic acid decarboxylase antibodies despite successful treatment with rituximab.僵人综合征：尽管利妥昔单抗治疗成功，但谷氨酸脱羧酶抗体持续升高。
J Clin Rheumatol. 2010 Aug;16(5):237-9. doi: 10.1097/RHU.0b013e3181e931fa.
5
Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff Person Syndrome.在僵人综合征中，长寿浆细胞和记忆 B 细胞产生致病性抗谷氨酸脱羧酶 65 自身抗体。
PLoS One. 2010 May 26;5(5):e10838. doi: 10.1371/journal.pone.0010838.
6
Stiff-person Syndrome with Waldenström Macroglobulinemia.僵人综合征合并华氏巨球蛋白血症
Intern Med. 2018 Nov 15;57(22):3313-3316. doi: 10.2169/internalmedicine.1043-18. Epub 2018 Jul 6.
7
Successful treatment of stiff person syndrome with sequential use of tacrolimus.他克莫司序贯治疗僵人综合征成功
J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1177-80. doi: 10.1136/jnnp-2013-305425. Epub 2013 May 28.
8
[Successful treatment with rituximab in a refractory Stiff-person syndrome].[利妥昔单抗成功治疗难治性僵人综合征]
Rev Neurol (Paris). 2012 Apr;168(4):375-8. doi: 10.1016/j.neurol.2011.09.008. Epub 2012 Feb 14.
9
Downbeating nystagmus and muscle spasms in a patient with glutamic-acid decarboxylase antibodies.一名患有谷氨酸脱羧酶抗体的患者出现下跳性眼球震颤和肌肉痉挛。
Am J Ophthalmol. 2005 Jul;140(1):142-4. doi: 10.1016/j.ajo.2004.12.052.
10
Rituximab treatment of stiff-person syndrome in a patient with thymoma, diabetes mellitus and autoimmune thyroiditis.利妥昔单抗治疗合并胸腺瘤、糖尿病和自身免疫性甲状腺炎的僵人综合征
J Clin Neurosci. 2010 Mar;17(3):389-91. doi: 10.1016/j.jocn.2009.06.015. Epub 2010 Jan 13.
引用本文的文献
1
Rituximab in stiff-person syndrome with glutamic acid decarboxylase 65 autoantibody: a systematic review.利妥昔单抗治疗伴谷氨酸脱羧酶65自身抗体的僵人综合征：一项系统评价
J Neurol. 2025 May 24;272(6):417. doi: 10.1007/s00415-025-13157-2.
2
Recent advances in autoimmune encephalitis.自身免疫性脑炎的最新进展
Arq Neuropsiquiatr. 2024 Dec;82(12):1-13. doi: 10.1055/s-0044-1793933. Epub 2024 Dec 20.
3
Expanding the Understanding of Stiff-Person Syndrome: Insights from 17 Cases in India.拓展对僵人综合征的认识：来自印度17例病例的见解
Ann Indian Acad Neurol. 2024 Jul 1;27(4):419-425. doi: 10.4103/aian.aian_92_24. Epub 2024 Aug 16.
4
An update on malignant tumor-related stiff person syndrome spectrum disorders: clinical mechanism, treatment, and outcomes.恶性肿瘤相关僵人综合征谱系障碍的最新进展：临床机制、治疗及预后
Front Neurol. 2023 Oct 4;14:1209302. doi: 10.3389/fneur.2023.1209302. eCollection 2023.
5
Therapies in Stiff-Person Syndrome: Advances and Future Prospects Based on Disease Pathophysiology.僵人综合征的治疗：基于疾病病理生理学的进展和未来前景。
Neurol Neuroimmunol Neuroinflamm. 2023 Apr 14;10(3). doi: 10.1212/NXI.0000000000200109. Print 2023 May.
6
Hematopoietic Stem Cell Transplantation for the Treatment of Autoimmune Neurological Diseases: An Update.造血干细胞移植治疗自身免疫性神经疾病：最新进展
Bioengineering (Basel). 2023 Jan 29;10(2):176. doi: 10.3390/bioengineering10020176.
7
Long-term Effectiveness of IVIg Maintenance Therapy in 36 Patients With GAD Antibody-Positive Stiff-Person Syndrome.36 例抗 GAD 抗体阳性僵人综合征患者静脉注射免疫球蛋白维持治疗的长期疗效。
Neurol Neuroimmunol Neuroinflamm. 2022 Jul 7;9(5). doi: 10.1212/NXI.0000000000200011. Print 2022 Sep.
8
Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies.僵人综合征和 GABA 能神经元兴奋性、免疫发病机制及抗体治疗更新：广泛性焦虑症抗体谱障碍。
Neurotherapeutics. 2022 Apr;19(3):832-847. doi: 10.1007/s13311-022-01188-w. Epub 2022 Jan 27.
9
Anti-amphiphysin positive stiff-person syndrome due to invasive ductal carcinoma in a male patient.男性患者因浸润性导管癌导致抗 Amphiphysin 阳性僵人综合征。
BMJ Case Rep. 2021 May 24;14(5):e237738. doi: 10.1136/bcr-2020-237738.
10
GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions.广泛性焦虑症抗体谱障碍：临床表型、免疫发病机制及治疗干预的进展
Ther Adv Neurol Disord. 2021 Mar 30;14:17562864211003486. doi: 10.1177/17562864211003486. eCollection 2021.
Zotero 插件